Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Mg Halpin

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Thorax|March 27, 2023
Do the 'missing millions' of COPD patients want to be found?David Mg Halpin
Expert Review of Respiratory Medicine|May 19, 2010
Preventing chronic obstructive pulmonary diseaseDavid Mg Halpin
Journal of Medical Economics|May 20, 2009
Symbicort: a pharmacoeconomic reviewDavid Mg Halpin
International Journal of Chronic Obstructive Pulmonary Disease|August 18, 2017
When is dual bronchodilation indicated in COPD?Mike Thomas, David Mg Halpin, Marc Miravitlles
International Journal of Chronic Obstructive Pulmonary Disease|October 25, 2017
Impact and prevention of severe exacerbations of COPD: a review of the evidenceDavid Mg Halpin, Marc Miravitlles, Norbert Metzdorf, et al.
International Journal of Chronic Obstructive Pulmonary Disease|February 25, 2015
Tiotropium HandiHaler(®) and Respimat(®) in COPD: a pooled safety analysisDavid Mg Halpin, Ronald Dahl, Christoph Hallmann, et al.
The European Respiratory Journal|November 6, 2025
Addressing the global challenges of COPD and asthma: a shared vision from the global initiative for chronic obstructive pulmonary disease (GOLD) and the global initiative for asthma (GINA)David Mg Halpin, Refiloe Masekela, Claus F Vogelmeier, et al.
International Journal of Chronic Obstructive Pulmonary Disease|October 4, 2016
Preference for different relaxation techniques by COPD patients: comparison between six techniquesMichael E Hyland, David Mg Halpin, Sue Blake, et al.
International Journal of Chronic Obstructive Pulmonary Disease|December 11, 2019
Cost-Effectiveness Of Once-Daily Single-Inhaler Triple Therapy In COPD: The IMPACT TrialAfisi S Ismaila, Nancy Risebrough, Melanie Schroeder, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Thorax|March 27, 2023
Do the 'missing millions' of COPD patients want to be found?David Mg Halpin
Expert Review of Respiratory Medicine|May 19, 2010
Preventing chronic obstructive pulmonary diseaseDavid Mg Halpin
Journal of Medical Economics|May 20, 2009
Symbicort: a pharmacoeconomic reviewDavid Mg Halpin
International Journal of Chronic Obstructive Pulmonary Disease|August 18, 2017
When is dual bronchodilation indicated in COPD?Mike Thomas, David Mg Halpin, Marc Miravitlles
International Journal of Chronic Obstructive Pulmonary Disease|October 25, 2017
Impact and prevention of severe exacerbations of COPD: a review of the evidenceDavid Mg Halpin, Marc Miravitlles, Norbert Metzdorf, et al.
International Journal of Chronic Obstructive Pulmonary Disease|February 25, 2015
Tiotropium HandiHaler(®) and Respimat(®) in COPD: a pooled safety analysisDavid Mg Halpin, Ronald Dahl, Christoph Hallmann, et al.
The European Respiratory Journal|November 6, 2025
Addressing the global challenges of COPD and asthma: a shared vision from the global initiative for chronic obstructive pulmonary disease (GOLD) and the global initiative for asthma (GINA)David Mg Halpin, Refiloe Masekela, Claus F Vogelmeier, et al.
International Journal of Chronic Obstructive Pulmonary Disease|October 4, 2016
Preference for different relaxation techniques by COPD patients: comparison between six techniquesMichael E Hyland, David Mg Halpin, Sue Blake, et al.
International Journal of Chronic Obstructive Pulmonary Disease|December 11, 2019
Cost-Effectiveness Of Once-Daily Single-Inhaler Triple Therapy In COPD: The IMPACT TrialAfisi S Ismaila, Nancy Risebrough, Melanie Schroeder, et al.
Pageof 1